TABLE 8.
Subgroup analyses.
| Characteristic | TG < 1.7 mmol/L, HR (95% CI) | P for interaction | TG ≥ 1.7 mmol/L, HR (95% CI) | P for interacion |
| Age, years | 0.5232 | 0.5480 | ||
| <30 | 0.985 (0.978, 0.991) | 0.986 (0.978, 0.994) | ||
| 30–40 | 0.987 (0.982, 0.993) | 0.986 (0.979, 0.992) | ||
| 40–50 | 0.981 (0.974, 0.987) | 0.986 (0.978, 0.994) | ||
| 50–60 | 0.981 (0.973, 0.989) | 0.979 (0.968, 0.989) | ||
| 60–70 | 0.978 (0.966, 0.990) | 0.976 (0.964, 0.989 | ||
| ≥70 | 0.984 (0.972, 0.996) | 0.979 (0.967, 0.992) | ||
| Gender | 0.9420 | 0.2144 | ||
| Male | 0.984 (0.980, 0.988) | 0.986 (0.981, 0.991) | ||
| Female | 0.984 (0.980, 0.988) | 0.982 (0.976, 0.987) | ||
| BMI (kg/m2) | 0.0132 | 0.9067 | ||
| <18.5 | 0.991 (0.930, 1.057) | 0.969 (0.908, 1.033) | ||
| ≥18.5, <24 | 0.977 (0.973, 0.980) | 0.982 (0.978, 0.986) | ||
| ≥24 | 0.986 (0.981, 0.992) | 0.983 (0.977, 0.988) | ||
| FPG (mmol/L) | 0.0170 | 0.2476 | ||
| ≤6.1 | 0.981 (0.978, 0.985) | 0.984 (0.980, 0.988) | ||
| >6.1 | 0.995 (0.984, 1.007) | 0.977 (0.966, 0.988) | ||
| ALT (U/L) | 0.0208 | 0.4824 | ||
| ≤40 | 0.984 (0.981, 0.988) | 0.983 (0.979, 0.987) | ||
| >40 | 0.975 (0.967, 0.983) | 0.986 (0.978, 0.994) | ||
| SBP (mmHg) | 0.2683 | 0.6130 | ||
| <140 | 0.983 (0.980, 0.987) | 0.984 (0.980, 0.988) | ||
| ≥140 | 0.987 (0.981, 0.993) | 0.982 (0.976, 0.989) | ||
| DBP (mmHg) | 0.0336 | 0.8686 | ||
| <90 | 0.982 (0.979, 0.985) | 0.984 (0.980, 0.988) | ||
| ≥90 | 0.991 (0.983, 1.000) | 0.983 (0.975, 0.992) |
Above model adjusted for age, sex, BMI, SBP, DBP, ALT, ALB, GLB, BUN, FBG, HDL-c, LDL-c.
In each case, the model is not adjusted for the stratification variable.
HR, Hazard ratios; CI: confidence, Ref: reference; eGFR, estimated glomerular filtration rate (mL/min⋅1.73 m2); NAFLD, non-alcoholic fatty liver disease.